PAUL V. MAIER
@paulvmaier
Director
Building APRICUS BIOSCIENCES, INC. as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Eton Pharmaceuticals, Inc. was founded in 2017 and has no closure on record.
Named alongside
- BRIAN D. DORSEYExecutive Officer
- Brian LianDirector
- CATHERINE D. BOVENIZERExecutive Officer
- Daniel J. O'ConnorDirector
- Judith W. DunnDirector
- KLEANTHIS G. XANTHOPOULOSDirector
- Margaret J. DalesandroDirector
- Margaret W. DalesandroDirector
- Andrew BollDirector
- Charles CasamentoDirector
- Charles J CasamentoDirector
- Mark BaumDirector
- Mark L. BaumDirector
- Norbert G RiedelDirector
- Sean BrynjelsenExecutive Officer, Director
- William Wilson TroutmanExecutive Officer
At MABVAX THERAPEUTICS HOLDINGS, INC.
- Gregory HansonChief Financial Officer
- Gregory P. HansonChief Financial Officer
- J. David HansenPresident, Chief Executive Officer and Chairman of the Board
- Jeffrey EisenbergDirector
- Jeffrey F. EisenbergDirector
- Jeffrey RavetchDirector
- Kenneth CohenDirector
- Kenneth M. CohenDirector
At Qualigen Therapeutics, Inc.
- Andrew J. RitterExecutive Officer, Director
- Braeden LichtiDirector
- Campbell BecherDirector
- Cody B. PriceDirector
- Cody PriceDirector
- Graydon BenslerDirector
- Ira E. RitterExecutive Officer, Director
- John W. BeckExecutive Officer
Contribution
PAUL's ideas, decisions and failures appear here once this profile is claimed.
Companies
- APRICUS BIOSCIENCES, INC.Pharmaceutical Preparations; formerly APRICUS BIOSCIENCES, INC.; filing with the SEC since 2008Director · Pharmaceuticals · SAN DIEGO, United States
- MABVAX THERAPEUTICS HOLDINGS, INC.Pharmaceutical Preparations; formerly TELIK INC; filing with the SEC since 2003Director · Biotechnology · SAN DIEGO, United States
- Qualigen Therapeutics, Inc.Finance Services; formerly AIxCrypto Holdings, Inc.; listed on Nasdaq as AIXC; filing with the SEC since 2009Director · Biotechnology · CARLSBAD, United States
- Eton Pharmaceuticals, Inc.Pharmaceutical Preparations; listed on Nasdaq as ETON; filing with the SEC since 2017Director · Pharmaceuticals · SAN DIEGO, United States · Founded 2017